The Trump Administration appears to have a tilted relationship with science and technology. Anything that has to do with climate change is suppressed or denied. Anything that is bold, loud, and expensive such as going to the moon or Mars is encouraged. With regards to the latter case, the sitting president just signed a directive that essentially ordered NASA to start doing moon landings again.
President Trump signed the directive on Monday, which is aimed at advancing the country’s space exploration efforts, CBS News reports. One of the primary mandates in the order is to have NASA put Americans back on the moon as preparation for the bigger Mars mission.
During the signing ceremony in the White House, Mr. Trump said that it was meant to "refocus America's space program on human exploration and discovery." He also noted how the country can dream again, saying "Imagine the possibility waiting in those big beautiful stars if we dare to dream big. That's what our country is doing again, we're dreaming big.”
This is just the latest move by the Trump administration to revive NASA’s space initiatives that were canned decades ago. Aside from reviving the National Space Council advisory body back in June, which has been dead for almost a decade, Vice President Mike Pence was also made its head.
While this may sound wonderful from a scientific and exploratory standpoint, some argue that the directive is simply one giant distraction, Futurism reports. The current administration is plagued by scandal after scandal, ranging from the investigation of collusion related to the Russian election tampering, to the numerous sexual harassment issues rocking the Republican party.
By making a grand ceremonial gesture such as reopening space exploration without any actual plans as to how to accomplish this, the Trump team is following the same tactics that the president has used many times before. Instead of developing clear-cut goals based on actual science, this seems to be another scheme to blind the public with overblown promises.


SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



